Phase 1 Investor is our most exclusive and expensive investment advisory at Stansberry Research. The service takes a "venture capital" approach to investing, seeking out small-cap speculative stocks with outstanding growth potential. The service focuses natural resource stocks and emerging technologies in the health care, life science, and biotechnology industries.

Editor Frank Curzio specializes in researching stock trading for less than $15. Over his 15-year career, Frank's approach to investing - which blends value, growth, top-down, and technical analysis - have regularly produced 200%, 300%, and 500% winners for his subscribers. He's been a guest on various media outlets including Fox Business News, CNBC's The Kudlow Report and CNBC's The Call. He has also been mentioned numerous times on Jim Cramer's Mad Money, is a featured guest on CNN Radio, and has been quoted in financial magazines and websites. Frank's "S&A Investor Radio" is one of the most widely followed financial broadcast in the country

Frank is an incredibly connected analyst… a critical attribute critical to the success of Phase 1. The stocks we focus on in this service aren't the kind you can "screen" for. You can only find the world's best opportunities in this space unless you have an extensive contact list of corporate insiders, scientific researchers, bankers, and consultants. After spending 15 years studying and networking with some of the smartest people on Wall Street, Frank has developed just such a contact list. We pay a premium for the benefit of Frank's experience and contacts. This is why Phase 1 Investor is our most expensive research service, and also why it's so successful.